Outlook Therapeutics (OTLK) Non Operating Interest Expenses (2015 - 2023)
Outlook Therapeutics (OTLK) posted Non Operating Interest Expenses of $3.16 million for FY2024 (year ended Sep 30, 2024), up 24.7% from $2.53 million in FY2023.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Non Operating Interest Expenses (2015 - 2023) Analysis & Trends
Since FY2015, Outlook Therapeutics has reported Non Operating Interest Expenses for 8 fiscal years.
- Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -1.9% (FY2019 to FY2024).
- The FY2024 figure stands as the highest annual Non Operating Interest Expenses since FY2019.
- Business Quant data shows OTLK's Non Operating Interest Expenses at $2.53 million in FY2023 and $1.76 million in FY2020 (-49.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -188,677.00 |
| Sep 30, 2023 | 82,128.00 |
| Jun 30, 2023 | 303.00 |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 360,648.00 |
| Jun 30, 2022 | 356,947.00 |
| Mar 31, 2022 | 418,327.00 |
| Dec 31, 2021 | 351,534.00 |
| Sep 30, 2021 | 269,182.00 |
| Jun 30, 2021 | 256,873.00 |
| Mar 31, 2021 | 250,409.00 |
| Dec 31, 2020 | 159,663.00 |
| Sep 30, 2020 | 19,031.00 |
| Jun 30, 2020 | 443,624.00 |
| Mar 31, 2020 | 696,151.00 |
| Dec 31, 2019 | 597,665.00 |
| Sep 30, 2019 | 210,183.00 |
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 1.12 Mn |
API Access
Outlook Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();